+45 21 54 64 08 finn.ketler@coop-med.com

Sales Challenges for Startups and niche players

size matters

You need to join forces to finance the expensive customer interaction

1:

Most classic Medical Device products are part of a treatment regime. Hence, they are part of an assortment and do not have blockbuster potential in their own right

3:

A key component of success is the size of the salesforce promoting the treatment regime a product fits into. A vast and stable sales pressure is required to reach the corners of a market. Therefore, the commercialization process is key to success. If not done correctly, even the right products will fail 

2:

MedTech products are sold via hundreds of wholesalers, and thousands of hospitals, and used by millions of nurses. To succeed, products need to fit into “solution selling, ” concepts of manufacturers will struggle to get attention on their own.

4:

In MedTech, you build companies, as the exit opportunity often lies after proof-of-sale at a level of €10-20 million. At this level, the industry is reassured; they can use their sales muscles to take innovative products to higher levels. They are reluctant to experiment with their valuable sales resource.

Solution:

You need to join forces to finance the expensive customer interaction

Sales efficiency matters

Sales Reps spend most of their time traveling

1:

Sales Reps spend most of their time in their car, driving from one customer to the next – unless they have a wide assortment, enabling them to visit more customers in a smaller geographical area

2:

The larger the territory Sales Reps have, the more time they waste in their car. If you have one Sale Rep in Denmark or a regional state in Germany, less than 25% of the time is likely to be spent in front of customers

3:

If a message is too narrow or specific for a diagnosed area, nurses will often not allow Sales Reps to be received (the door stays closed).

Solution:

Join forces to reduce sales regions to a manageable size

Solution selling is required

The chance of succeeding with a one-product approach is limited

1:

Well-educated nurses and doctors diagnose and treat all aspects of a ‘ ‘patient’s condition

3:

The large players in the MedTech industry all have a wide assortment to sell. Some focus on a few therapeutic areas in which they want to be a global leader, and others want to dominate a specific customer type like hospitals or homecare with a wide assortment. All have hundreds or even thousands of products, packed in therapy solutions for an individual user group. All have hundreds of sales reps

2:

Nurses have minimal time to talk to company representatives, and often bans have been implemented to avoid inappropriate time spent on armies of Sales Reps. Hence, messages must cover a therapy area and be highly relevant to get any attention

4:

The chance of succeeding with a one-product approach is limited, and the cost of a noticeable sales force is more than likely to outgrow revenues

Solution:

You need to join forces to be able to present a product package

Funding drying out

– medical launch processes are a lot longer than most investors expect

‘DO’ers are required

– You need experienced, locally anchored sales managers doing the job for you